Beneficial effects of leflunomide on cardiac myosin-induced experimental autoimmune myocarditis in rats

International Journal of Immunotherapy

Volumn 14, Issue 1, 1998, Pages 9-21

  Dimitrijevic, M ^a   Milenkovic, M ^a   Milosavljevic, P ^b   Stojic Vukanic, Z ^a   Colic, M ^b   Bartlett, R ^c  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY OF DEFENCE   (Serbia)

^c SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FREUND ADJUVANT; IMMUNOMODULATING AGENT; LEFLUNOMIDE; MYOSIN; NONSTEROID ANTIINFLAMMATORY AGENT; TERIFLUNOMIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; DISEASE COURSE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; INFLAMMATORY INFILTRATE; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MYOCARDITIS; NONHUMAN; RAT;

EID: 0031950526     PISSN: 02559625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Rose N.R , Herskowitz A., Neumann D.A. Autoimmunity in myocarditis: models and mechanisms. Clin. Immunol. Immunopathol., 68, 95, 1993.
2. Brown C.A, O'Connell J.B. Myocarditis and idiopathic dilated cardiomyopathy. Am. J. Med., 99, 267, 1995
3. Moze S.S., Adolph R.J Myocarditis: unresolved issues in diagnosis and treatment Clin. Cardiol., 13, 69, 1990.
4. Dimitrijevic M., Vasiljevic Z., Vuckovic-Dekic L J., Spasic S The involvement of immune reactions in cardiac damage during acute myocardial infarction: role of cell-mediated immune response. Panminerva Med , 46, 93, 1996.
5. Rose N.R., Neumann D.A., Herskowitz A Autoimmune myocarditis: concepts and questions. Immunol. Today, 12, 253, 1991.
6. O'Conell J.B Immunosuppression for dilated cardiopathy. N Engl. J. Med., 321, 1119, 1989
7. Davis M.J How can myocarditis be diagnosed and should it be treated? Br. Heart J., 68, 346, 1992
8. Mason J.W., Billingham M.E., Ricci D.R Treatment of acute inflammatory myocarditis assisted by endomyocardial biopsy. Am J Cardiol., 45, 1037, 1980.
9. Daly K., Richardson P.J., Jolsen E.G., et al. Acute myocarditis. Role of histological and virological examination in the diagnosis and assessment of immunosuppressive treatment. Br. Heart J., 51, 30, 1984
10. Lange L.G., Schreiner G.F. Immune mechanisms of cardiac disease. N. Engl. J. Med., 330, 1129, 1994.
11. Talwar K.K., Goswami K.C., Chopra P., Dev V., Shrivastava S., Malhotra A. Immunosuppressive therapy in inflammatory myocarditis: long-term follow-up. Int. J. Cardiol., 34, 157, 1992.
12. Beisel K.W., Traystman M.D. Autoimmune myocarditis: a marine model. Immunol Ser , 52, 267, 1990.
13. Rabausch-Starz I , Schwaiger A., Grunewald K., Muller-Hermelink H-K , Neu N. Persistence of virus and viral genome in myocardium after Coxackievirus B3-induced murine myocarditis. Clin. Exp. Immunol, 96, 69, 1994
14. Pummerer C , Berger P, Fruhwirth M., Ofner C., Neu N Cellular infiltrase, major histocompatibility antigen expression and immunopathogenic mechanisms in cardiac myosin-induced myocarditis. Lab Invest., 65, 538, 1991.
15. Neu N., Craig S W, Rose N R., Alvarez F L., Beisel K.W. Coxackie-virus induced autoimmune myocarditis in mice: cardiac mosin autoantibodies do not cross-react with the virus Clin Exp. Immunol., 69, 566, 1987.
16. Gaunt C., Higdon A., Bowers D., Maull E , Wood J., Crawley R. What lessons can be learned from animal model studies in viral heart disease? Scand J. Infect. Dis., 88, 49, 1993.
17. Gauntt C.J., Higdon A.L., Arizpe H M , et al. Epitopes shared between Coxackievirus B3 (CVB3) and normal heart tissue contribute to CVB3-induced murine myocarditis. Clin Immunol. Immunopathol., 68, 129, 1993
18. Gauntt C J., Arizpe H.M., Higdon A L., et al. Molecular mimicry. anti-coxackievirus B3 neutralizing monoclonal antibodies, and myocarditis. J. Immunol., 154, 2983, 1995.
19. Kodama M., Matsumoto Y., Fujiwara M., Masani F , Izumi T , Shibata A A novel experimental model of giant cell myocarditis induced in rats by immunization with cardiac myosin fraction Clin. Immunol. Immunopathol., 57, 250, 1990.
20. Bartlett R.R., Schleyerbach R. Immunopharmacological profile of a novel isoxazol derivate. HWA 486, with potential antirheumatic activity. I Disease-modifying action on adjuvant arthritis of the rat Int. J Immunopharm , 7, 7, 1985.
21. Bartlett R.R , Dimitrijevic M , Mattar T., et al. Leflunomide (HWA 486). a novel immunomodulating compound for the treatment of autoimmune disorders and reactions leading to transplantation rejection. Agents Actions 32, 10, 1991.
22. Ogawa T , Inazy M., Gotoh K Hayashi S. Effects of leflunomide on glomerulonephntis induced by antibasement membrane antibody in rats Agents Actions, 31, 321, 1990.
23. Smith-Long L., Glaser B , Weimer L K , et al Efficacy of novel immunomodulators leflunomide and rapamycin in autoimmune uveitis FASEB J., 6, A1048, 1992
24. Stosic-Grujicic S , Dimitrijevic M., Bartlett R.R A novel immunomodulating agent - leflunomide - inhibits experimental autoimmune diabetes in mice. Transpl. Proc., 28, 3072, 1996
25. Xiao F., Chong AS-F, Bartlett R R., Williams J.W. Leflunomide: a promising immunosuppressant in transplantation In. Thompson A W , Starzl T.E., (Eds) "Immunosuppressive Drugs. Developments in Antirejection Therapy" Edward Arnold. London, 1994, pp 203-212
26. Murakami U , Uchida K., Hiratsuka T Cardiac myosin from pig heart ventricle purification and enzymatic properties J Biochem., 80, 611, 1976
27. Kodama M , Zhang S , Hanawa H . et al Effects of 15-deoxysperqualin on experimental autoimmune giant cell myocarditis of the rat. Circulation. 91 1116, 1995
28. Wolfgram L J , Beisel K W Herskowitz A , Rose N R Variations in the susceptibility of coxackievirus B3-induced myocarditis among different strains of mice. J. Immunol, 136, 1846, 1986.
29. Mickey W.F., Gonatas N.K., Kimura H., Wilson D B Identification and quantitation of T lymphocyte subsets found in the spinal cord of the Lewis rat during acute experimental allergic encephalomyelitis. J. Immunol., 131, 2805, 1983
30. Mason D Y, Damon M.E. Alkaline phosphatase and peroxidase for double immunoenzymatic labeling of cellular constituents. J. Clin. Pathol., 31, 454 1978.
31. Colic M., Popovic Lj., Gasic S . et al. Immunohistochemical characterization of rat thymic non-lymphoid cells. II Macrophages and granulocytes defined by monoclonal antibodies. Immunology, 69, 416, 1990.
32. Colic M., Gasic S., Popovic Lj., Dujic A. Lymphatic tissues and in vivo immune responses. In Imhof B., Berrih-Aknin S , Ezine S., (Eds ). Marcel Dekker Inc , New York, 1991, pp 61-68.
33. Bartlett R R., Anagnostopulos H , Zielinski T, Mattar T, Schleyerbach R. Effects of leflunomide on immune responses and models of inflammation. Springer Sem Immunopathol., 14, 381, 1993.
34. Ztelinski T., Muller H J , Schleyerbach R., Bartlett R R. Differential effects of leflunomide on leukocytes: inhibition of rat in vivo adhesion and in vitro oxidative burst without affecting surface marker modulation Agents Actions, 41, C276, 1994.
35. Mattar T., Kochhar K., Bartlett R.R., Bremer E.G., Finnegan A Inhibition of the epidermal growth factor receptor tyrosine kinase activity by leflunomide. FEBS Lett., 334, 161. 1993.
36. Nikcevich D.A., Finnegan A , Chong A.S F , Williams J.W , Bremer E.G. Inhibition of interleukin 2 (IL-2)-stimulated tyrosine kinase activity by leflunomide. Agents Actions, 41, C279, 1994.
37. Zielinski T, Zeitter D., Mullner S , Bartlett R R. Leflunomide, a reversible inhibitor of pynmidine biosynthesis? Inflamm. Res, 44. S207, 1995
38. Williamson R A , Yea C.M , Robson P.A , et al. Dihydroorotats dehydrogenase is a high affinity binding protein for A 771726 and mediator of a range of biological effects of the immunomodulatory compound J. Biol Chem., 270. 22467, 1995.
39. Dimitrijevic M., Bartlett R R. Leflunomide, a novel immunomodulating drug, inhibits homotypic adhesion of peripheral blood and synovial fluid mononuclear cells in rheumatoid arthritis. Inflamm Res . 45, 556, 1996.
40. Mladenovic V, Domljan Z , Rozman B , et al Safety and effectiveness of leflunomide in the treatment of patients with active rheumatoid arthritis Results of a randomized, placebocontrolled phase II study Arthr Rheum., 38, 1595, 1995
41. Suzuki K A histological study on experimental autoimmune myocarditis with special reference to initiation of the disease and cardiac dendritic cells. Virchows Arch., 426, 493, 1995.
42. Thomas R., Lipsky P.E. Could endogenous self-peptides presented by dendritic cells initiate rheumatoid arthritis? Immunol. Today, 17, 559, 1996
43. Neu N., Pummerer C., Rieker T., Berger P T-cells in cardiac myosin-induced myocarditis. Clin. Immunol Immunopalhol., 68, 107, 1993.
44. Spencer S.C., Fabre J W. Characterization of the tissue macrophage and the interstitial dendritic cells as distinct leukocytes normally resident in the connective tissue of rat heart J. Exp Med , 171, 1841, 1990.
45. Cella M , Sallusto F., Lanzavecchia A Origin. maturation and antigen presenting function of dendritic cells. Curr. Opin Immunol., 9, 10, 1997
46. Smith S.C., Allen P.M. Myosin-induced acuse myocarditis is a T-cell mediated disease. J. Immunol , 147, 2141, 1991
47. Kodama M., Matsumoto Y, Fujiwara M In vivo lymphocyte-mediated myocardial injuries demonstrated by adoptive transfer of experimental autoimmune myocarditis. Circulation 85, 1918, 1992.
48. Hanawa H , Kodama M., Inornate T., et al Anti-αβ T-cell receptor antibody prevents the progression of experimental autoimmune myocarditis Clin. Exp. Immunol., 96, 470, 1994.
49. Neu N , Ploier B , Ofner C Cardiac myosin-induced myocarditis: heart autoantibodies are not involved in the induction of the disease J. Immunol , 145, 4094, 1990.
50. Wegmann K.W , Zhao W , Griffin A.C., Hickey W F Identification of myocarditogenic peptides derived from cardiac myosin capable of inducing experimental allergic myocarditis in the Lewis rat. The utility of a class II binding motif in selecting self-reactive peptides. J. Immunol., 153, 892, 1994
51. Oppenheimer-Marks N , Davis L S., Brogue D.T., Ramberg J , Lipsky P.E. Differential utilization of ICAM-1 and VCAM-1 during the adhesion and transendothelial migration of human T lymphocytes. J. Immunol., 147, 2913, 1991
52. Oppenheimer-Marks N., Lipsky P E. The role of cell adhesion in the evolution of inflammatory arthritis. In Wegner C.D. (Ed.) "Adhesive Molecules" Academic Press, London, 1994, pp. 141-161.
53. Hynes R O Integrins. versality, modulation and signaling in cell adhesion. Cell, 69, 11, 1992.